Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer

Clinical trial NCT05851365 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05851365
Sponsor: Robert Flavell, MD, PhD
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Localized Prostate Carcinoma

Start date: 2023-07-06
Primary completion: 2027-12-31
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.